News
Clinical Trials Arena on MSN11d
Northwestern University enrols first subject in trial of drug for pericarditisNorthwestern University in Illinois, US, has enrolled the first subject in a Phase III trial of Cardiol Therapeutics' drug ...
Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by ...
Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago. Based on a successful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback